Biomarkers: diagnosis and risk assessment in sepsis

Prompt diagnosis, intervention, and risk assessment are critical in caring for septic patient but remain difficult with currently available methods. Biomarkers may become useful adjuncts to clinicians and ultimately serve as targets for future therapeutic trials in sepsis. The most relevant markers...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Clinics in chest medicine Ročník 29; číslo 4; s. 591
Hlavní autori: Ventetuolo, Corey E, Levy, Mitchell M
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 01.12.2008
Predmet:
ISSN:1557-8216, 1557-8216
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Prompt diagnosis, intervention, and risk assessment are critical in caring for septic patient but remain difficult with currently available methods. Biomarkers may become useful adjuncts to clinicians and ultimately serve as targets for future therapeutic trials in sepsis. The most relevant markers are reviewed in this article, including interleukin-6, C-reactive protein, procalcitonin, triggering receptor expressed on myeloid cells-1, and biomarker panels.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1557-8216
1557-8216
DOI:10.1016/j.ccm.2008.07.001